Pain medicine

Ultrasound-guided Percutaneous Cryoneurolysis for the Treatment of Pain after Traumatic Rib Fracture: A Randomized, Active-controlled, Participant- and Observer-masked Study

AnesthesiologyPublished Randomised controlled trial

Authors' conclusion

Ultrasound-guided percutaneous cryoneurolysis improves maximum inspired lung volume while concurrently decreasing pain and opioid consumption after traumatic rib fracture.

Study context

Population
Adults with one to six traumatic rib fractures
Participants
11 vs 9
Comparison
Cryoneurolysis vs Peripheral nerve block
  • Cryoneurolysisn = 11
  • Peripheral nerve blockn = 9reference
Primary endpoint
Maximum inspired volume measured with an incentive spirometer
Follow-up
Day after the procedure
Methodological detailsactive-controlled, participant- and observer-masked
  • Active-controlled
  • Participant- and observer-masked

Primary result

As reported in the abstract

Maximum inspired volume

Mean difference

496

95% CI −428 to 1,420P = 0.269

unadjusted; t test

Adjusted mean difference

793 ml

95% CI 273–1,312P = 0.005

adjusted for covariates (e.g., baseline lung volume); analysis of covariance

Further findings

Total cumulative oxycodone equivalents · t test

P = 0.013

OutcomeCryoneurolysisPeripheral nerve blockP value
Improvement from baseline in maximum inspired volumeT test · median, ml1,000 (IQR 1,000–1,375)300 (IQR 0–1,000)P = 0.002
Percent improvement over baseline in maximum inspired volumeT test · median100% (IQR 90%–188%)30% (IQR 0%–50%)P = 0.003

Average daily pain scores · First month

Generally lower in the cryoneurolysis group throughout the first month

Original publication

Ultrasound-guided Percutaneous Cryoneurolysis for the Treatment of Pain after Traumatic Rib Fracture: A Randomized, Active-controlled, Participant- and Observer-masked Study. Anesthesiology. Published 19 December 2024. doi:10.1097/aln.0000000000005328

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.